PROM

Worldwide Preterm Birth And PROM Testing Industry to 2028 - Featuring Qiagen, Hologic and Biosynex Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 30, 2021
Women, Other Health, Consumer, Health, Baby, Maternity, Particle-size distribution, PROM, Risk, CAGR, POC, Preterm birth, UNICEF, Family, Health, Female, Hospital, Pregnancy, Development, American College of Obstetricians and Gynecologists, Geography, American College, ACOG, Awareness, Population growth, Birth control, Gynaecology

Preterm births are not specific to a particular geography and have been recognized as a worldwide concern.

Key Points: 
  • Preterm births are not specific to a particular geography and have been recognized as a worldwide concern.
  • The risk of preterm births typically escalates with increasing average age of pregnant women.
  • With growing awareness about preterm births and its consequence, the tendency of pregnant women to enroll for Premature Rupture of Membranes (PROM) testing during their pregnancy is anticipated to increase, for reassurance and monitoring of symptoms of preterm birth.
  • Point-of-Care (POC) diagnostics have drastically altered the methodology of testing in various fields.

Phreesia Announces Acquisition of Insignia Health, LLC, Redoubling Its Commitment to Improve Patients’ Experience and Outcomes

Retrieved on: 
Monday, December 13, 2021
Software, Technology, General Health, Health, Faculty, Software as a service, PROM, U.S. Securities and Exchange Commission, Forward-looking statement, University, PAM, Patient satisfaction, SEC filing, Health, Securities Exchange Act of 1934, Centers for Medicare & Medicaid Services, Growth, Medicare, National Quality Forum, NHS, COVID-19, Acquisition, CMS, Annual report, Patient Activation Measure, Securities Act of 1933, SEC, LLC, Research, Patient, Security (finance), Terminology, Efficiency, NQF, Risk, Technology, Medical imaging, Pharmaceutical industry, Risk management

The acquisition is a natural extension of Phreesias commitment to enabling patients to become more active participants in their care.

Key Points: 
  • The acquisition is a natural extension of Phreesias commitment to enabling patients to become more active participants in their care.
  • Phreesia acquired Insignia from its co-founders, Chris Delaney and Craig Swanson, the University of Oregon and its other holders of membership interest.
  • PAM results are used to improve risk identification, guide patient support and evaluate impact as a patient-reported outcome measure (PROM).
  • The subsequent years of research have revealed the essential role that activation plays in determining outcomes for patients.

Oncology eCOA - How the New FDA Draft Guidelines Change COA Implementation, Upcoming Webinar Hosted by Xtalks

Retrieved on: 
Thursday, October 14, 2021
Science, Food, Industry, Tell Us the Truth, New, FDA, Data collection, Collection, Pros, US, Element, Research, Guest appearance, Foundation, PROM, Medical device

In this webinar, Signant 's clinical experts provide a summary, as well as interpretation and analysis, of the draft guidance with a view to establish foundations for future study design and planning.

Key Points: 
  • In this webinar, Signant 's clinical experts provide a summary, as well as interpretation and analysis, of the draft guidance with a view to establish foundations for future study design and planning.
  • For more information, or to register for this event, visit Oncology eCOA What the New FDA Draft Guidelines Tell Us.
  • Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community.
  • Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.)

Zimmer Biomet Announces New Data Supporting Clinical Benefits of mymobility® with Apple Watch® at AAOS 2021

Retrieved on: 
Tuesday, August 31, 2021
TKA, THA, Program, Preferred walking speed, Life, IPhone, Movement, Intention, SEC, Leadership, Health, Apple Watch, AAOS, William H. Harris (orthopaedic surgeon), Prom, PCOM, Solution, Apple Inc., Orthopedic surgery, Smartphone, General manager, Knee, Pain, U.S. Securities and Exchange Commission, Annual general meeting, Use, Walking, Patient, Technology, New Mexico, MD, ROSA, Randomized controlled trial, PROM, Twitter, Surgeon, KOOS, Hip, Motion, Goal, UC, Elective surgery, Exercise, Pcom, Connected health, Private Securities Litigation Reform Act, User experience, Artificial intelligence, American Academy, American Academy of Orthopaedic Surgeons, Trial of the century, Robotics, NYSE, SDR, News, Compliance, Culture, Medical device, Medicine, Surveying, Medical imaging, Mobile phone, Dentistry

mymobility with Apple Watch is a part of ZBEdge , Zimmer Biomet's suite of connected digital and robotic technologies designed to deliver actionable insights with the goal of improving patient outcomes.

Key Points: 
  • mymobility with Apple Watch is a part of ZBEdge , Zimmer Biomet's suite of connected digital and robotic technologies designed to deliver actionable insights with the goal of improving patient outcomes.
  • The data are being presented at the American Academy of Orthopaedic Surgeons (AAOS) 2021 Annual Meeting being held on August 31 to September 3 in San Diego.
  • "The introduction of mymobility with Apple Watch underscores Zimmer Biomet's commitment to evaluating the real-world clinical benefits of a remote care management platform after orthopedic surgery," said Robert Kraal, Vice President and General Manager, Connected Health at Zimmer Biomet.
  • Apple Watch and iPhone are trademarks of Apple, Inc., registered in the US and other countries.